These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 30275248)
1. Obesity and Endocrine Management of the Patient With Duchenne Muscular Dystrophy. Weber DR; Hadjiyannakis S; McMillan HJ; Noritz G; Ward LM Pediatrics; 2018 Oct; 142(Suppl 2):S43-S52. PubMed ID: 30275248 [TBL] [Abstract][Full Text] [Related]
2. Short stature and pubertal delay in Duchenne muscular dystrophy. Wood CL; Straub V; Guglieri M; Bushby K; Cheetham T Arch Dis Child; 2016 Jan; 101(1):101-6. PubMed ID: 26141541 [TBL] [Abstract][Full Text] [Related]
3. Bone Health and Endocrine Care of Boys with Duchenne Muscular Dystrophy: Data from the MD STARnet. Weber DR; Thomas S; Erickson SW; Fox D; Oleszek J; Pandya S; Venkatesh Y; Westfield C; Ciafaloni E; J Neuromuscul Dis; 2018; 5(4):497-507. PubMed ID: 30149461 [TBL] [Abstract][Full Text] [Related]
4. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations. Bowden SA; Connolly AM; Kinnett K; Zeitler PS J Neuromuscul Dis; 2019; 6(1):31-41. PubMed ID: 30614808 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Manzur AY; Kuntzer T; Pike M; Swan A Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031 [TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Manzur AY; Kuntzer T; Pike M; Swan A Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215 [TBL] [Abstract][Full Text] [Related]
7. Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy. Wood CL; Cheetham TD; Hollingsworth KG; Guglieri M; Ailins-Sahun Y; Punniyakodi S; Mayhew A; Straub V BMC Pediatr; 2019 Apr; 19(1):131. PubMed ID: 31023296 [TBL] [Abstract][Full Text] [Related]
8. Administration of glucocorticoids in boys with Duchenne muscular dystrophy. Gutierrez A; England JD Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1703-8. PubMed ID: 24305455 [TBL] [Abstract][Full Text] [Related]
9. Corticosteroids for the treatment of Duchenne muscular dystrophy. Matthews E; Brassington R; Kuntzer T; Jichi F; Manzur AY Cochrane Database Syst Rev; 2016 May; 2016(5):CD003725. PubMed ID: 27149418 [TBL] [Abstract][Full Text] [Related]
10. A review of nutrition in Duchenne muscular dystrophy. Davidson ZE; Truby H J Hum Nutr Diet; 2009 Oct; 22(5):383-93. PubMed ID: 19743977 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Denosumab for Glucocorticoid-Induced Osteoporosis in an Adolescent Patient with Duchenne Muscular Dystrophy: A Case Report. Kumaki D; Nakamura Y; Sakai N; Kosho T; Nakamura A; Hirabayashi S; Suzuki T; Kamimura M; Kato H JBJS Case Connect; 2018; 8(2):e22. PubMed ID: 29642113 [TBL] [Abstract][Full Text] [Related]
12. Different bone health progression patterns and early-stage risk marker in glucocorticoid-treated ambulatory Duchenne muscular dystrophy. Zhou L; Zhou H; Xu H; Sun X; Chen X; Fan P; Cai X; Wang Q Osteoporos Int; 2024 Jun; 35(6):997-1005. PubMed ID: 38277031 [TBL] [Abstract][Full Text] [Related]
15. Impact of corticotherapy, nutrition, and sleep disorder on quality of life of patients with Duchenne muscular dystrophy. Jeronimo G; Nozoe KT; Polesel DN; Moreira GA; Tufik S; Andersen ML Nutrition; 2016 Mar; 32(3):391-3. PubMed ID: 26701140 [TBL] [Abstract][Full Text] [Related]
16. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. McDonald CM; Henricson EK; Abresch RT; Duong T; Joyce NC; Hu F; Clemens PR; Hoffman EP; Cnaan A; Gordish-Dressman H; Lancet; 2018 Feb; 391(10119):451-461. PubMed ID: 29174484 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-Associated Demise of a Patient With Duchenne Muscular Dystrophy. Brahmsteadt AE; Bach JR; Pishdad R; Cespedes L; Pierucci P Am J Phys Med Rehabil; 2020 Dec; 99(12):e146-e148. PubMed ID: 32195738 [TBL] [Abstract][Full Text] [Related]
18. Skeletal disproportion in glucocorticoid-treated boys with Duchenne muscular dystrophy. Kao KT; Joseph S; Capaldi N; Brown S; Di Marco M; Dunne J; Horrocks I; Shepherd S; Ahmed SF; Wong SC Eur J Pediatr; 2019 May; 178(5):633-640. PubMed ID: 30762116 [TBL] [Abstract][Full Text] [Related]
19. Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy. Tian C; Wong BL; Hornung L; Khoury JC; Miller L; Bange J; Rybalsky I; Rutter MM Neuromuscul Disord; 2016 Nov; 26(11):760-767. PubMed ID: 27614576 [TBL] [Abstract][Full Text] [Related]